Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AweMed Spray
- Development stage
- Unknown
- Lead developer
- Orenda Pharma
- Administration
- Topical
01
Overview
AweMed Spray is a topical over-the-counter (OTC) skincare product developed by Orenda Pharma in collaboration with dermatologists in Singapore. It is specifically formulated for the management of eczema and the relief of pruritus (itching). The product is part of the AweMed Series, which emphasizes skin barrier restoration and irritation relief. As a consumer-facing therapeutic product rather than a clinical-stage drug candidate, it is marketed for daily use to soothe sensitive or compromised skin. It is delivered as a topical spray for ease of application on affected areas.
- Brand names
- AweMed Spray
- Other names
- AweMed
Beyond the preview
Go deeper on AweMed Spray.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AweMed Spray.